Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.5.2 (
NQO1
)
6,196
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dehydrogenases are an important target for the development of cancer therapeutics. Dehydrogenases either produce or consume NAD(P)H, which is fluorescent but at a wavelength where many compounds found in chemical libraries are also fluorescent. By coupling dehydrogenases to
diaphorase
, which utilizes NAD(P)H to produce the fluorescent molecule resorufin from resazurin, the assay can be red-shifted into a spectral region that reduces interference from compound libraries. Dehydrogenases that produce NAD(P)H, such as
isocitrate dehydrogenase 1
(
IDH1
), can be read in kinetic mode. Dehydrogenases that consume NAD(P)H, such as mutant
IDH1
R132H, can be read in endpoint mode. Here, we report protocols for robust and miniaturized 1,536-well assays for WT
IDH1
and
IDH1
R132H coupled to
diaphorase
, and the counterassays used to further detect compound interference with the coupling reagents. This coupling technique is applicable to dehydrogenases that either produce or consume NAD(P)H, and the examples provided here can act as guidelines for the development of high-throughput screens against this enzyme class.
...
PMID:Diaphorase Coupling Protocols for Red-Shifting Dehydrogenase Assays. 2707 81
Oxidative damages have adverse effects on mammals. Growing studies have focused on exploring new antioxidants. Here, we report that
Lactobacillus frumenti
increases the total antioxidation capacity activities and decreases the total reactive oxygen species levels in porcine intestinal epithelial cells. Comparative proteomics revealed that expressions of peroxiredoxin 2,
isocitrate dehydrogenase 1
,
NAD(P)H dehydrogenase
quinone 1, antioxidant protein 1, and metallothionein-2A, which are associated with antioxidant defense system, were significantly increased with
L. frumenti
treatment. In germ-free mice,
L. frumenti
treatment also remarkably improves the intestinal antioxidant capacity. We further illustrated that nitric oxide production-mediated by nitric oxide synthase 1 activation is essential for
L. frumenti
-induced improvements in intestinal epithelial antioxidant capacity and barrier function. This study suggested that
L. frumenti
may be a potential probiotic used to prevent oxidative stress-induced aging and diseases in mammals.-Nie, Y., Hu, J., Hou, Q., Zheng, W., Zhang, X., Yang, T., Ma, L., Yan, X.
Lactobacillus frumenti
improves antioxidant capacity
via
nitric oxide synthase 1 in intestinal epithelial cells.
...
PMID:
Lactobacillus frumenti
improves antioxidant capacity
via
nitric oxide synthase 1 in intestinal epithelial cells. 3126 91